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Abstract
Breast cancer is among the principal cause of cancer fatalities in women. Notwithstanding 
the use of chemotherapy and advances in drug delivery techniques, cancer-related 
morbidity and mortality are still increasing with the increase in resistance to known 
therapeutics. This dilemma has drastically reduced the rate of survival from this deadly 
disease, creating a dire need for new drugs, especially from natural sources that would 
exhibit similar or better anticancer properties while imparting minimal adverse side 
effects. Among the bewildering hallmark capabilities of cancer is the evasion of apop-
tosis while in its course to immortality. Thus, induction of apoptosis in cancerous cells 
is an important breakthrough that cannot be ignored. There are, however, two major 
pathways of apoptosis in mammals, viz., the death receptor–mediated pathway (extrin-
sic pathway) and the mitochondrial-mediated pathway (intrinsic pathway). Artonin E, 
a prenylated flavonoid isolated from the stem bark of Artocarpus elasticus, was seen to 
induce apoptosis in MCF-7 breast cancer cells, hence halting the breast cancer cells in 
their journey to immortality.
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1. Introduction
Breast cancers, like other forms of cancer, possess the ability for uncontrolled proliferation 
while resisting cell death [1]. This undue proliferation is a consequence of apoptosis evasion 
as well as loss of normal cell cycle control. Apoptosis is an efficient and uniquely regulated 
mode of cell death, involving the interplay of many factors. In mammals, there are two major 
pathways of apoptosis viz., the death receptor mediated pathway (extrinsic pathway) and 
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the mitochondrial mediated pathway (intrinsic pathway). Caspases are the key regulatory 
proteins for both pathways [2]. The extrinsic pathway requires the binding of ligands such as 
tumor necrosis factor α (TNFα), Fas ligand (Fas-L) and TNF-related apoptosis-inducing ligand 
(TRAIL) to the death receptor on cell surfaces and corresponding transduction of signals lead-
ing to apoptosis [3]. The intrinsic pathway, on the other hand, is mediated by the release of 
cytochrome c by the mitochondrial following DNA damage. The released cytochrome c then 
induces the formation of apoptosomes composed of apoptotic protease activating factor 1 
(Apaf-1), procaspase 9, and either ATP or dATP [4]. Caspase 9 is a downstream factor that 
activates the executioner caspase-3, which cleaves substrates such as Poly (ADP-ribose) poly-
merase (PARP) [5]. The activated caspase 3 then initiates the caspase cascade that culminates 
in the demolition of the cell [6].
In this study, the colorimetric microculture tetrazolium assay [7] was employed to access the 
cells viability while assays including morphology studies, Annexin V-FITC Assay and DNA 
fragmentation were thereafter utilized to ascertain the mode of the cell death.
2. Materials and methods
The chemical and reagents used in the study were; MTT (3-[4, 5-dimethylthiazol-2-yl]-2,5-di-
phenyltetrazolium bromide) (PhytoTechnology Laboratories, USA), DMSO (dimethylsulf-
oxide) (Fisher Scientific, UK), Dulbecco’s Modified Eagle’s Medium (DMEM) and Roswell 
Park Memorial Institute medium (RPMI 1640) powders with L-glutamine (GIBCO, New 
Zealand), fetal bovine serum (FBS), horse serum, trypsin–EDTA, phosphate-buffered saline 
(PBS) tablets and penicillin (10,000 U/mL)–streptomycin (10 mg/mL) (Sigma-Aldrich, USA), 
acridine orange (AO) and propidium iodide (PI), annexin V-FITC (BD Pharmingen), and gel 
red nucleic acid stain and apoptotic DNA ladder detection kit (Abcam, USA).
2.1. Cell culture
The cell culture procedures were carried out in an aseptic condition in a Class II biohaz-
ard cabinet according to good cell culture practice (GCCP) guidelines. The MCF-7 breast 
cancer cell line (ATCC, USA) were grown in 25 cm2 tissue culture flasks (TPP, Switzerland) 
and incubated in an incubator (Binder, Germany) at 37°C under a humidified atmosphere 
of 5% CO
2
. The cells were maintained in RPMI supplemented with 10% FBS and 1% peni-
cillin–streptomycin. Upon reaching about 80% confluency, the cells were washed twice 
with PBS and 1 mL of trypsin–EDTA solution was added to detach the monolayer cells. 
The trypsin was inactivated by the addition of the complete cell growth medium and the 
cells were collected by centrifugation at 1000 rpm (Hettich Universal 32 R centrifuge, DJB 
Labcare Ltd., UK) for 5 min before discarding the medium. The cell count was determined 
using a hemocytometer counting chamber (Marienfeld, Germany) and about 0.5 to 1 × 106 
cells were subcultured into a fresh 25 cm2 tissue culture flask containing 6 ml of fresh 
medium at the subcultivation ratio of 1:4. The cultures were incubated at 37°C under 5% 
CO
2
 and 95% air.
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2.2. Cryogenic preservation and recovery
The cells were preserved in liquid nitrogen to avoid loss of their original characteristics. 
Briefly, the cells growing in the exponential phase were subcultured. Following detachment 
and centrifugation, the cells were resuspended in freezing medium containing 90% FBS and 
10% DMSO, as a cryoprotective agent, to yield a final cell density of 2 to 5 × 106 cells/mL. 
Subsequently, 1 mL of cell suspension was transferred into each labeled cryotube and allowed 
to stand at −20°C for 2 hours and at −80°C overnight before storage in liquid nitrogen (−196°C) 
(CBS Cryosystem). When needed, the cells were recovered by thawing with gentle agitation in 
water bath at 37°C for approximately 2 min. The cell suspension was transferred into a sterile 
15 mL centrifuge tube (TPP, Switzerland) containing prewarmed complete growth medium 
in a biosafety cabinet and centrifuged at 1000 rpm (Hettich Universal 32 R centrifuge, DJB 
Labcare Ltd., UK) for 5 min at room temperature to remove the cryoprotective agent (DMSO). 
Finally, the cell pellets were resuspended in culture media and transferred to a 25cm2 culture 
flask (TPP, Switzerland), incubated at 37°C in a CO
2
 incubator. After 2 days, the medium was 
replaced with fresh complete growth medium.
2.3. Plating
At about 80% confluency, the cells were collected and the concentration was determined 
using a hemocytometer. Briefly, 0.5 × 105 cells/mL were dispensed into each well of a 96-well 
flat bottom tissue culture plate. To obtain the desired plating concentration of 0.5 × 105 cells/
mL, the initial cell concentration was adjusted with culture medium using the following 
formula:
  M 
1
   V 
1
  =  M 
2
   V 
2
 (1)
where M
1
 is the initial cell concentration, V
1
 is the initial cell suspension volume, M
2
 is the 
final cell concentration, and V
2
 is the final cell suspension volume.
Using a multichannel pipette, 100 μL of the cell suspension was dispensed into each well, 
except the blank wells, which received 200 μL of culture medium. The cell-seeded plate was 
incubated overnight at 37°C to facilitate attachment.
2.4. Preparation of the test agents
Artonin E was kindly donated by Dr. Najihah Hashim of the Department of Pharmacy, Faculty 
of Medicine, University of Malaya. The compound was isolated from Artocarpus elasticus, char-
acterized and identified as reported by [8]. The standard agents, Tamoxifen and Paclitaxel 
were purchase from Sigma Aldrich, St. Louis, MO, USA. These agents were dissolved in 
DMSO and normal saline respectively and then diluted with respective medium with highest 
final DMSO concentration of 0.1% for in vitro cell culture studies. They were diluted serially 
using culture medium to obtain concentrations in the range of 1.56–100 μM. About 100 μL of 
each concentration of Artonin E, Tamoxifen and Paclitaxel solutions was added into appropri-
ate wells in four replicates.
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2.5. Microculture tetrazolium assay
The colorimetric microculture tetrazolium assay ([7] was used to assess breast cancer cell 
viability. The tetrazolium dye is converted into an insoluble formazan by the action of 
nicotinamide adenine dinucleotide hydrogenase present in metabolically active cells. This 
cellular conversion into a purple-colored formazan is directly proportional to the number of 
viable cells. Briefly, exponentially growing cells were seeded into a 96-well flat bottom tis-
sue culture plate at a density of approximately 0.5 × 104 cells/well and allowed to adhere to 
the plate by incubating at 37°C under 5% CO
2
 and 95% air overnight. Following cell attach-
ment, the cells were incubated with the tested compounds at concentrations ranging from 
1.56 to 100 μM. Control cells were treated with 0.01% of DMSO, which was equivalent to the 
amount of DMSO used as vehicle. After each of the 24, 48 and 72 h treatment time period, 
20 μL of 5 mg/mL of MTT solution was added to each well and the plate was reincubated for 
4 h to facilitate catalysis by mitochondrial dehydrogenases. Next, 100 μL DMSO was added 
to each well to solubilize the formazan crystals. The absorbances of the resultant solutions 
were determined colorimetrically at 570 nm. The experiment was performed in triplicate.
We conducted a nonlinear regression analysis and utilized the GraphPad Prism software to 
fit a dose-response curve. The concentration of the compound that triggered a 50% growth 
inhibition was indicated at different time interval in Figure 1. The percentage viability used in 
fitting the dose-response curve was calculated using the following formula:
  % of cell viability =   A T  ___
 A 
C
 
× 100 (2)
Figure 1. Viability of MCF-7 cell line treated with Artonin E. The half maximum growth inhibitory concentrations (IC50) were: 6.90, 5.10 and 3.77 μM Artonin E at 24, 48 and 72 h, respectively.
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Where the absorbance reading of treated samples is indicated as A
T
 while the absorbance of 
control samples treated with 0.01% of DMSO equivalent to the concentration used in dissolv-
ing the tested agent is depicted as A
C
.
2.6. Cell morphological study
Acridine Orange (AO) and propidium iodide (PI) double staining assay was employed to 
determine the effect of Artonin E in the induction of breast cancer cell death. A total of 3 × 105 
MCF-7 breast cancer cells were seeded in a six-well plate and exposed to various treatment 
concentrations of Artonin E (1.56–100 μM) at varying time points (24–72 h). The adherent 
MCF-7 cells were trypsinized, and centrifuged at 2000 rpm (Hettich Universal 32 R centrifuge, 
DJB Labcare Ltd., UK) for 5 min. The pellet was washed with ice-cold PBS, re-centrifuged 
before suspending in 20 μL of PBS. The cells were thereafter stained on ice with 20 μL dye 
containing 10 μg/mL of AO with 10 μg/mL of PI. Carl Zeiss Axioskop plus-2 fluorescence 
microscope was used to visualize aliquots of 20 μL of the cell suspension. Three fields each 
containing at least 200 cells were immediately assessed for viability, early and late apoptosis 
as well as necrosis [9]. The experiment was performed in triplicate.
2.7. Annexin V-FITC assay
Apoptosis was also investigated by detection of externalized phosphatidylserine using the 
Annexin V Kit (BD Pharmingen, USA). The cell preparation was carried out in accordance 
with the manufacturer’s protocol. The prepared cells were finally subjected to flow cytometric 
analysis using laser emitting excitation light at 488 nm and a BD flow cytometer equipped 
with an Argon laser (Cyan ADP, DAKO, Glostrup, Denmark). The data were analyzed using 
the Summit V4.3 software.
2.8. DNA fragmentation analysis
Qualitative DNA fragmentation (Roche) kit was used in this analysis. Briefly, after trypsin-
ization, 1 × 106 cells were collected and washed twice with PBS. The cells were then pelleted 
by centrifugation at 3000 rpm for 5 min, the supernatant removed and replaced with 200 μL 
of fresh PBS. The sample was thereafter lysed with 200 μL binding/lysis buffer consisting 
of 6 M guanidine-HCl, 10 mM urea, 10 mM Tris–HCl, 20% Triton X-100 (v/v), pH 4.4 and 
incubated for 10 min at 15–25°C. After the incubation, 100 μL of isopropanol was added 
and the mixture was filtered through a high pure spin filter tube combined with a clean 
collection tube and centrifuged at 8000 rpm for 1 min. The flow-through was discarded and 
the filter tube was combined again with the collection tube before washing with 500 μL of 
washing buffer consisting of 20 mM NaCl, 2 mM Tris–HCl, pH 7.5 in 20 mL with the addi-
tion of 80 mL ethanol. This washing step was done twice before spinning the tube dry at 
13,000 rpm (Eppendorf 5424 microcentrifuge, USA) for 10 s to remove any residual washing 
buffer.
The extracted DNA was eluted into a fresh collection tube with 200 μL of prewarmed (70°C) 
elution buffer (10 mM Tris) and recentrifuged at 8000 rpm for 1 min. The quality of the 
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extracted DNA was assessed with a nanodrop spectrophotometer (nanodrop lite spectro-
photometer, Thermo Scientific, USA). The DNA sample was mixed with 1× loading dye and 
electrophoresed on 1% agarose gel 75 V for 1 h and stained with GelRed™ nucleic acid gel 
stain. The fragmented DNA was visualized under UV transilluminator and photographed 
with a chemiluminescence image analyzer system (Chemi-Smart, Vilber Lourmat, Germany).
2.9. Statistical analysis
All data collected were analyzed using the GraphPad Prism 5.0 (GraphPad Software Inc., La 
Jolla, CA, USA). One way analyses of variance was performed, followed by Turkey’s post hoc 
tests to compare replicate means of treatment and control groups. The significance was set at 
p < 0.05.
3. Results
3.1. Growth inhibitory effect of Artonin E on MCF-7 breast cancer cells
Artonin E, at concentrations of 6.9, 5.10 and 3.77 μM induced a half maximal growth inhibi-
tory effect on estrogen receptor-positive breast cancer cells (Figure 1) at 24, 48 and 72 h 
respectively.
3.2. Artonin E treated MCF-7 breast cancer cells displayed morphology of apoptosis
The results of the AO and PI double staining analysis showed that Artonin E treated breast 
cancer cells displayed morphological features typical of apoptosis. These features included 
chromatin condensation and membrane blebbing. The control breast cancer cells which were 
not exposed to Artonin E had their normal nuclear structure displayed as green fluorescence. 
Early apoptotic cells were observed as bright green fluorescence resulting from the interposi-
tion of acridine orange with the fragmented DNA whereas late stage apoptosis (Figure 2C 
and D) was observed as reddish-orange, resulting from the binding of propidium iodine to 
denatured DNA. The apoptosis inducing effect of Artonin E was observed to be time and 
concentration dependent.
Challenging the cancer cells with Artonin E caused a significant (p < 0.05) loss in the propor-
tion of viable MCF-7 breast cancer cells (Figure 3) from 94.5% to 67, 38, and 21.5% after treat-
ment with 3, 10, and 30 μM Artonin E respectively. There was no significant (p ≥ 0.05) increase 
in necrotic breast cancer cells except after exposure to 30 μM of Artonin E. This percentage 
decreased. There was a concentration and time dependent significant (p < 0.05) increase in the 
proportion of cells that entered the apoptotic phase.
3.3. Annexin V-FITC assay flowcytometric analysis
The externalized phosphatidyl serine was detected with Annexin V-FITC dye as an indication 
of apoptosis induced upon treatment of breast cancer cells with Artonin E. From the results, 
there was a significant (p < 0.05) shift in the population of the breast cancer cells from viability 
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Figure 2. Acridine orange/propidium iodide double staining of MCF-7 cells after 24 h exposure. (A) Control, (B) 3, 
(C) 10, (D) 30 μM Artonin E. VC = viable cells; BL = cell membrane blebbing; CC = chromatin condensation; EA = early 
apoptosis; LA = late apoptosis; MN arginated nuclear chromatin; SN secondary necrosis. Magnification: 200×.
Figure 3. Quantification of early and late apoptotic MCF-7 cells after AO/PI double staining analysis. All values are 
mean ± standard deviation. *at each time point, means significantly different for control at p < 0.05.
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Figure 4. Representative histogram analysis of the Annexin V assay in MCF-7 cells treatment with Artonin E at 24 and 
48 h. Viable cells population are shown in the lower left quadrant, while those undergoing early apoptosis are in the 
lower right quadrant. The upper right quadrant shows cells at late stage of apoptosis, and in upper left corner, cells at 
the necrotic stage are shown.
to late apoptosis (Figure 4). This effect was concentration as well as time dependent. After 
24 h exposure of the cancer cells to Artonin E, the percentage viability decreased from 97.78% 
to 81.27, 36.33 and 12.0 6% when treated with 3, 10 and 30 μM of Artonin E respectively.
3.4. DNA fragmentation analysis
Another unique feature of apoptosis is DNA fragmentation which can be visualized by aga-
rose gel electrophoresis [10]. From the results, nuclear DNA fragmentation occurred after 
treatment with Artonin E. This was observed in the breast cancer cells (Figure 5) in compari-
son to the untreated control group which showed intact DNA.
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4. Discussion
The death of cancer cells in a tumor is the ultimate goal of cancer drug discovery. Unlike nor-
mal cells, cancer cells possess the ability to proliferate uncontrollably while evading apoptosis. 
Apoptosis induction is thus a valuable characteristic of a potential anticancer drug. Hence, the 
cytotoxic effect of a compound can be accessed by investigating its growth inhibition on the 
target cancer cells. It is also vital to examine the mode of cell death induced by the compound. 
In this study, Artonin E, previously shown to be drug-like with a better in silico growth inhibi-
tory properties when compared with similar structural analogues [11], was evaluated for its 
in vitro growth inhibition and mode of cell death induced in MCF-7 breast cancer cell line.
Artonin E was found to significantly inhibit the proliferation of this breast cancer cells in 
a dose and time dependent manner. At 24, 48 and 72 h, Artonin E showed half maximal 
inhibitory concentrations of 6.90, 5.10 and 3.77 μM, respectively. MCF-7 is estrogen recep-
tor positive, progesterone positive and HER2 (human epidermal growth factor 2) positive 
and has wild type p53 [12]. Etti et al. [11] reported the in silico affinity of Artonin E to the 
human estrogen receptor α and pin pointed Artonin E as having greater binding affinity 
for the estrogen receptor α among the reported structural analogues from the Artocarpus. 
Figure 5. DNA fragmentation in MCF-7 cells treated with Artonin E after 24 h. The positive control cells were treated 
with 4 μg/mL camptothecin, the DNA marker is a 1 kb ladder.
Apoptosis-Inducing Effect of Artonin E in Breast Cancer
http://dx.doi.org/10.5772/intechopen.79205
29
It was also reported that the prenylation together with the 41, 51 vicinal diol groups in Artonin 
E had enhanced its affinity to the human estrogen receptor α. This affinity of Artonin E 
to the human estrogen receptor can be said to be mostly responsible for its better growth 
inhibition in MCF-7 cells observed in this study. Consistent with our findings, Obiorah 
et al. [13] discovered that ERα was exclusively responsible for the apoptosis induction of 
genistein, equol, and coumestrol, compounds which are structurally similar to Artonin E. 
They confirmed the phenomenon by a gene knockdown of ERα which prevented growth 
inhibition and apoptosis induced by these phytoestrogens. These support the involvement 
of the estrogen receptor in the growth inhibitory potential of Artonin E. Similarly, Turner 
et al. [14] also reported that prenylflavones show selectivity to estrogen receptors. Thus, it is 
of no doubt, that the affinity of Artonin E for the estrogen receptor is a possible basis for the 
observed sensitivity of MCF-7 breast cancer cells to the compound.
Various modes of cell death include apoptosis, necrosis and autophagy. However, from the 
results of this study, Artonin E provoked morphological features typical of apoptosis in the 
Artonin E treated breast cancer cells. In support of this, Carou et al. [15] and Gerl and Vaux 
[16], reported that apoptosis results in unique morphological changes including cell shrink-
age, membrane alteration, DNA fragmentation and nuclear condensation. These features were 
observed in this study after treating the breast cancer cells with Artonin E. Succinctly, agents 
that trigger apoptosis are very essential in the management of cancer, giving that a unique hall-
mark of cancer cells is apoptosis evasion which is also implicated in its pathogenesis [17]. Hence, 
induction of apoptosis becomes a strategy for cancer drug discovery [18].
A compromise in the phospholipid membrane asymmetry of a cell, results in the externaliza-
tion of phosphatidylserine. To further strengthen the assessment of the apoptotic mode of cell 
death, annexin V FITC in combination with a DNA binding fluorochrome, PI were utilized 
[9, 19, 20]. In this study, Artonin E has been seen to significantly reduce the population of 
viable breast cancer cells in a concentration and time dependent manner while increasing 
the population undergoing apoptosis. Thus, treatment of breast cancer cells with Artonin 
E distorted the integrity of the lipid bilayer of the cancer cells, exposing their phospholipid 
as detected in this study. These observations qualifies apoptosis as the mode of cell death 
induced by Artonin E.
Apoptotic endonucleases in the course of apoptosis, degrades chromosomal DNA into frag-
ments [21]. This fragmented DNA can be visualized in a gel electrophoresis. In this study, after 
treating the cancer cells with Artonin E, its DNA was seen to have degraded into fragments 
in comparison to the untreated control. This DNA fragment induction by Artonin E, confirms 
apoptosis as the mode of cell death [22] which was also seen in the morphology of Artonin E 
treated breast cancer cells and the Annexin V-FITC flowcytometric assays.
5. Conclusion
Artonin E inhibited the unregulated growth of breast cancer cells and induced apoptosis in 
the cancer cells. It produced enhanced cytotoxicity on the estrogen receptor positive MCF-7 
cells thus, halting its progression to immortality.
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